Monitra Health: Rewriting the Future of Cardiac Monitoring with upBeat®
10 months ago Rituka MMonitra Health, a pioneering startup based at T-Hub, Hyderabad, has successfully secured USD 1.5 million in its Pre-Series A funding round. Led by Equanimity Ventures and Kotak Alternate Asset Managers, this investment fuels the growth of Monitra’s revolutionary remote cardiac monitoring platform, upBeat®, across domestic and global markets.
Poised to revolutionize cardiac care for both Indian and global markets, Hyderabad-based Monitra Health is India’s first full-stack remote cardiac monitoring platform built for a massive scale. Their flagship product, upBeat®, is a game-changer, aiding healthcare professionals in diagnosing unexplained fainting, dizziness, and palpitations with exceptional accuracy and world-class reporting capabilities.
Proven Success and a Clear Vision for the Future!
With three pre-clinical studies, one clinical study presented at the European Heart Rhythm Association, patents secured in India and Australia (global patents pending), and over 10,000 patients monitored, Monitra Health boasts a proven track record. They hold patents in key markets, have secured ISO-13485 and CDSCO certifications, and are actively pursuing CE and 510(k) FDA approvals for global reach.
But the team’s vision extends far beyond cardiac monitoring. They aim to establish upBeat® as the gold standard for at-home patient monitoring, expanding into diverse healthcare sectors like stroke monitoring, high-risk pregnancy, diabetes management, and even competitive sports within the next five years.
Funding Fuels Domestic Expansion, International Ambitions
This pre-Series A funding fuels Monitra’s next phase of growth. The focus? Domestic expansion, securing international certifications, and developing the platform to monitor a wider range of bio-physiological signals like brain strokes, oxygen saturation, blood pressure, and respiratory rate. Speaking on the importance of the investment, Mr. Ravi Bhogu, CEO and Founder of Monitra Health states, “This investment is pivotal for our growth, driving domestic expansion, international certifications, and innovation. We aim to shape the future of healthcare at Monitra Health.” Their sights are set on international markets like Southeast Asia, Africa, Europe, and North America once CE and FDA certifications are secured.
Recognizing Monitra’s immense potential, Mr. Rajesh Sehgal, Managing Partner, Equanimity Ventures says, “Monitra Health is addressing a significant worldwide issue with their innovative IP-backed platform. We are excited to join forces with them on the mission of expanding this technology globally.” Further, Mr. Dhiraj Rajendran, Partner, Kotak Private Equity adds; “Monitra’s indigenously built solution empowers prescribers and patients. We are happy to support Ravi and his team in their endeavor to scale Monitra to newer heights. Monitra’s indigenously built solution leverages AI/ML algorithms to give real-time inputs to prescribers and patients about arrhythmias, further enabling them to make tailored decisions.” Lastly, Nidhi Saraf of Key Venture concludes, “Monitra’s capital efficiency, proprietary technology, and robust platform position them for a profitable high growth. They are a formidable player in the global health monitoring segment.“
Monitra Health’s story is one of innovation, dedication, and a vision for a healthier future. With upBeat® leading the charge, the company is poised to revolutionize the way we monitor and manage our health, both at home and in the clinic.
